In four patients (cases 1-4) the diagnosis of lymphoma was definitely established by bronchoalveolar lavage. In two of these patients (cases 1 and 4) this diagnosis was entirely unexpected. Though one patient (case 1) was in a subleukaemic phase, examination of mononuclear cells from the blood showed only 50o abnormal lymphoid cells. This had not been found before by routine analysis of white cells. The other patient (case 4) was not leukaemic, and no other organs apart from the left lung were affected. In cases 1 and 2 the diagnosis of malignant lymphoma was confirmed by bone marrow biopsy (case 1, immunoblastic lymphoma; case 2, lymphoplasmacytic immunocytoma). In case 3 a bronchial biopsy showed diffuse infiltration of the bronchial mucosa by small lymphoid cells consistent with lymphocytic lymphoma. In case 4 bronchoscopic biopsies did not show lymphoma, and a histological diagnosis was not available.
In the three remaining patients (cases 5-7) pulmonary infiltration with haematological malignancies was ruled out by analysis of lavage fluid cells with monoclonal antibodies. In all three cases the cell differentials in the lavage fluid were abnormal, showing a predominance of T lymphocytes as evidence of alveolitis, but atypical lymphoid or myeloid cells were not present. In cases 5 and 6 drug induced interstitial pneumonitis was the most probable diagnosis; this was supported in case 5 by the complete clearing of the lung shadowing after cyclophosphamide was withdrawn. In case 7 the decreased ratio of helper to suppressor T cells and the increase in Leu-7 natural killer cells in lavage fluid suggested hypersensitivity pneumonitis due to organic dusts.2 3 This diagnosis was confirmed by the history (exposure to parakeets) and by positive serum precipitins against antigens of this bird.
Comment
We conclude that bronchoalveolar lavage and analysis of the recovered cells for surface markers should be considered as a noninvasive diagnostic approach in cases of pulmonary shadowing associated with malignant haematological disorders. Compared with biopsy procedures, bronchoalveolar lavage is a safe method that does not carry an increased risk of bleeding in patients with clotting defects.
